Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6426
Source ID: NCT01201928
Associated Drug: Comparator Administered In Parent Trial
Title: Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus
Interventions: DRUG: Comparator administered in parent trial|DRUG: Technosphere Insulin Inhalation Powder
Outcome Measures: Primary: Comparison of change from baseline to final treatment visit in pulmonary function (FEV1 FVC, TLC and DLco) between treatment Groups (TI vs comparator arms) using ANCOVA models., Baseline values are the average of Visit 1 (Week -7) and Visit 4 (Week 0). |
Sponsor/Collaborators: Sponsor: Mannkind Corporation
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 3
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2010-10
Completion Date: 2012-03
Results First Posted:
Last Update Posted: 2012-12-06
Locations: Valley Research, Fresno, California, 93720, United States|Health Care Partners Medical Group, Long Beach, California, 90806, United States|Laureate Clinical Research Group, Atlanta, Georgia, 30308, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Alta Pharmaceutical Research Center, Dunwoody, Georgia, 30338, United States|LaPorte County Institute for Clinical Research Inc., Michigan City, Indiana, 46360, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Billings Clinic Research Center, Billings, Montana, 59101, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|North Shore Diabetes and Endocrine Associates, New Hyde Park, New York, 11042, United States|Endocrine Research Physicians East PA, Greenville, North Carolina, 27834, United States|Israel Hartman MD, Arlington, Texas, 76014, United States|Dallas Diabetes & Endocrine Center, Dallas, Texas, 75230, United States|SAM Clinical Research Center, San Antonio, Texas, 78229, United States
URL: https://clinicaltrials.gov/show/NCT01201928